Cosec 40 mg (Capsule (Enteric Coated))

Unit Price: ৳ 8.05 (6 x 7: ৳ 338.10)
Strip Price: ৳ 56.35

Medicine Details

Indications

  • Gastric and duodenal ulcer
  • NSAID-associated duodenal and gastric ulcer
  • Prophylaxis in patients with a history of NSAID-associated duodenal and gastric ulcer
  • Gastro-esophageal reflux disease
  • Long-term management of acid reflux disease
  • Acid-related dyspepsia
  • Severe ulcerating reflux esophagitis
  • Prophylaxis of acid aspiration during general anesthesia
  • Zollinger-Ellison syndrome
  • Helicobacter pylori-induced peptic ulcer

Pharmacology

  • Inhibitor of gastric acid secretion
  • Blocks hydrogen-potassium-adenosine triphosphatase (H+/K+ ATPase) enzyme system
  • Onset of the antisecretory effect occurs within one hour
  • Maximum effect occurs within two hours
  • Inhibition of secretion lasts up to 72 hours
  • Secretory activity returns gradually over 3 to 5 days after discontinuation

Dosage

  • 20 mg once daily for benign gastric and duodenal ulcer
  • 20 mg once daily for NSAID-associated duodenal or gastric ulcer
  • 20 mg once daily for gastro-esophageal reflux disease
  • 10-20 mg daily for long-term management of acid reflux disease
  • 10-20 mg once daily for acid-related dyspepsia
  • 40 mg on the preceding evening, then 40 mg 2-6 hours before surgery for prophylaxis of acid aspiration
  • Initially 60 mg once daily for Zollinger-Ellison syndrome
  • 20 mg twice daily for Helicobacter pylori eradication regimen in peptic ulcer disease
  • 10-20 mg once daily for 4-12 weeks in severe ulcerating reflux esophagitis (Child>1 year)

Administration

  • IV Injection for prophylaxis of acid aspiration, duodenal ulcer, gastric ulcer or reflux esophagitis
  • IV Infusion for prophylaxis of acid aspiration
  • Slow intravenous injection for IV Injection
  • Intravenous infusion over a period of 20-30 minutes or more for IV Infusion
  • Use within 4 hours of reconstitution for IV Injection
  • Use within 12 hours when Omeprazole is dissolved in saline and within 6 hours when dissolved in 5% Dextrose for IV Infusion

Interaction

  • Decreased intragastric acidity may reduce the absorption of ketoconazole
  • Metabolised in the liver through cytochrome P450, can delay the elimination of diazepam, phenytoin, and warfarin
  • Monitoring of patients receiving warfarin or pheytoin is recommended
  • Plasma concentrations of Omeprazole and clarithromycin are increased during concomitant administration
  • No evidence of an interaction with phenacetin, theophylline, caffeine, propranolol, metoprolol, cyclosporin, lidocaine, quinidine, estradiol, amoxycillin or antacids

Contraindications

  • Known hypersensitivity to Omeprazole
  • Gastric ulcer suspected to be malignancy

Side Effects

  • Skin rash, urticaria, and pruritus
  • Photosensitivity, bullous eruption, erythema multiforme, angioedema, and alopecia
  • Diarrhoea and headache
  • Constipation, nausea/vomiting, flatulence, and abdominal pain
  • Dry mouth, stomatitis, and candidiasis
  • Paraesthesia
  • Dizziness, light headedness, and feeling faint
  • Somnolence, insomnia, and vertigo
  • Reversible mental confusion, agitation, depression, and hallucinations
  • Arthritic and myalgic symptoms
  • Blurred vision, taste disturbance, peripheral oedema, increased sweating, gynaecomastia, leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, anaphylactic shock, malaise, fever, bronchospasm, encephalopathy, hepatitis, interstitial nephritis, hepatic failure, increases in liver enzymes

Pregnancy & Lactation

  • No adverse effects on pregnancy or the health of the fetus/newborn child
  • Omeprazole can be used during pregnancy
  • No information available on the passage of Omeprazole into breast milk or its effects on the neonate

Precautions & Warnings

  • Avoid concomitant use of clopidogrel
  • Observational studies suggest an increased risk for osteoporosis-related fractures with PPI therapy
  • Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patients treated long-term with Omeprazole
  • Concomitant use of PPIs with methotrexate may lead to methotrexate toxicities

Therapeutic Class

  • Proton Pump Inhibitor

Storage Conditions

  • Keep in a dry place away from light and heat
  • Keep out of the reach of children

Related Brands